Flow’s headset is the first tDCS device approved by the FDA ...

With nearly 20 percent of U.S. adults affected by depression, the prevalence of this mental health condition drives many to explore relief from its most challenging symptoms. A recent study offers ...

Unsupervised, at-home use of transcranial direct current stimulation (tDCS) was no better than a sham control for treating a major depressive episode, a randomized trial showed. The PSYLECT trial of ...

BOSTON, March 11, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, and Sooma Medical, a world-leading provider of ...

As at-home, do-it-yourself (DIY) brain stimulation devices like transcranial direct current stimulation (tDCS) gain popularity for common psychiatric conditions like depression, anxiety, and ...

A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study. A device that delivers direct stimulation to ...

Depression affects approximately 280 million people all over the world, and disproportionately affects the female population — it is 50% more common in women than men. Treatments range from ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...

Home-based transcranial direct current stimulation (tDCS) improved attention in adults with attention deficit-hyperactivity disorder (ADHD) who were not taking stimulant medications, a randomized ...